Company HLB bioStep Co.,Ltd.

Equities

A278650

KR7278650007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Bio Diagnostics & Testing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
3,575 ^KRW	+1.13%		-4.16%	+15.70%

Apr. 25	HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.	CI
Mar. 08	Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023.	CI

HLB bioStep Co Ltd, formerly KNOTUS Co Ltd, is a Korea-based company mainly engaged in non-clinical trial business. The Company operates through three segments. The Non-clinical Test Consignment Agency Business segment conducts non-clinical is mainly engaged in the test on newly developed substances such as new drugs ,and tests the efficacy and pharmacodynamics of substances. In addition, this segment is engaged in the test of the safety of substances. The Bioinfra Business segment is engaged in animal laboratory design, construction, and maintenance. In addition, this segment provides equipment delivery. The Pet Medical Business segment is engaged in the development of veterinary medicine and the sale of companion animal products.

Number of employees: 161

KRW in Million	2022	Weight	2023	Weight	Delta
Bioinfrastructure 41.0 %	23,762	27.5 %	21,667	41.0 %	-8.82%
Non-clinical CRO 37.9 %	32,171	37.3 %	20,038	37.9 %	-37.71%
Pet Medical 21.0 %	30,344	35.2 %	11,109	21.0 %	-63.39%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 99.5 %	86,277	100.0 %	52,550	99.5 %	-39.09%
International 0.5 %	-	-	264	0.5 %	-

Managers	Title	Age	Since
Do-Hyeong Kim CEO	Chief Executive Officer	44	-
Jung-Hwan Moon CEO	Chief Executive Officer	61	-
Do-Guk Son DFI	Director of Finance/CFO	49	-
Chang-Hyun Baek AUD	Comptroller/Controller/Auditor	57	-

Members of the board	Title	Age	Since
Yang-Gon Jin BRD	Director/Board Member	58	-
Chang-Yoon Lim BRD	Director/Board Member	58	-
Jung-Hwan Moon CEO	Chief Executive Officer	61	-
Do-Hyeong Kim CEO	Chief Executive Officer	44	-
Hyun-gyu Go BRD	Director/Board Member	42	-
Mi-Won No BRD	Director/Board Member	49	-
Sang-Hyun Sung BRD	Director/Board Member	59	-
Tae-Geun Han BRD	Director/Board Member	50	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	86,324,714	61,051,055 ( 70.72 %)	508,815 ( 0.5894 %)	70.72 %

Name	Equities	%	Valuation
HLB CO., LTD. 14.81 %	12,650,832	14.81 %	42 M ₩
Do-Hyeong Kim 4.197 %	3,585,909	4.197 %	12 M ₩
HLB THERAPEUTICS CO.,LTD. 1.880 %	1,606,500	1.880 %	5 M ₩
Hyun-sun Cho 0.1855 %	158,522	0.1855 %	531 057 ₩
Seon Cho Hyun 0.1855 %	158,522	0.1855 %	531 057 ₩
Soon-suk Hwang 0.1843 %	157,500	0.1843 %	527 633 ₩
KNOTUS Co. Ltd. ESOA 0.0297 %	25,380	0.0297 %	85 024 ₩
DFA Australia Ltd. 0.000692 %	591	0.000692 %	1 980 ₩

Name	Equities	%	Valuation
HLB INNOVATION CO.,LTD. 2.93%	2,074,688	2.93%	9,616,386 $
HLB SCIENCE INC. 7.96%	1,304,348	7.96%	4,209,757 $
INVENTAGE LAB, INC. 0.26%	22,000	0.26%	195,610 $

HLB bioStep Co., Ltd.

38 Academy-ro 79beon-gil Yeonsu-gu

22014, Inchon

http://www.knotus.co.kr

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
HLB BIOSTEP CO.,LTD.	+15.70%	224M
EXACT SCIENCES CORPORATION	-25.91%	10.94B
IOVANCE BIOTHERAPEUTICS, INC.	+65.87%	3.75B
GUARDANT HEALTH, INC.	-28.10%	2.27B
BGI GENOMICS CO., LTD.	-10.06%	2.25B
VERACYTE, INC.	-24.72%	1.54B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+51.76%	1.18B
SEEGENE, INC.	-2.84%	754M
CAREDX, INC	-8.25%	529M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-28.16%	469M

Bio Diagnostics & Testing